查看文章

Abstract Study Objectives To estimate economic cost of common sleep disorders in Australia for 2019–2020. Methods Costs were estimated for obstructive sleep apnea (OSA), insomnia, and restless legs syndrome (RLS) using prevalence, financial, and nonfinancial data from national databases. These included:(1) financial costs associated with health care, informal care, productivity losses, non-medical accident costs, deadweight loss from taxation/welfare inefficiencies; and (2) nonfinancial costs associated with loss of well-being. They were expressed in US dollars ().ResultsEstimatedoverallcostofsleepdisordersinAustraliain2019–2020(population:25.5million)was 35.4 billion (OSA 13.1billion;insomnia 13.3 billion, RLS 9.0billion).Ofthis,thefinancialcostcomponentwas 10.0 billion, comprised of: health system costs 0.7billion;productivitylosses 7.7 billion; informal care 0.2billion;other,mainlynon …